Pancreatic kallikrein joint angiotensin-converting enzyme inhibitor treatment of diabetic microalbuminuria.doc
- 1、本文档共7页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Pancreatic kallikrein joint angiotensin-converting enzyme inhibitor treatment of diabetic microalbuminuria
PAGE \* MERGEFORMAT 7
Pancreatic kallikrein joint angiotensin-converting enzyme inhibitor treatment of diabetic microalbuminuria
[Abstract] Objective: To observe the pancreatic kallikrein (TPK) combined angiotensin-converting enzyme inhibitor (ACEI) treatment of diabetic microalbuminuria in clinical effect. Methods: 60 subjects were divided into control and combination therapy group, after 12 weeks of treatment, testing before and after treatment 24 h urinary albumin changes in results: before and after treatment 24 h urinary albumin were significantly changed (P lt;0.01), decreased by 37.60% and 66.3% and the control group, combined treatment group effect is more pronounced (P lt;O.01). Conclusion: Pancreatic kallikrein than the combined angiotensin-converting enzyme inhibitors, angiotensin-converting enzyme inhibitors alone slow down or reverse the early diabetic kidney disease to clinical proteinuria and chronic renal failure progress.
[Keywords] ACEI TPK urinary albumin
To explore how to more effectively slow down and reversal of diabetic nephropathy (DN) of development, this study of 60 patients with early DN patients, clinical observations, of which 60 cases using Enalapril pancreatic kallikrein (Yee open) treatment of early DN to observe the 12 weeks through the urinary albumin (UAER), results were satisfactory, the report is as follows.
1 Materials and Methods
1.1 General Information
Collected in October 2005 hospitalized patients in December 2006, according to WHO (1999) diagnostic criteria for diabetes were included 60 cases of type 2 diabetes are overweight body. Decile method with random row of the list control group of 30 patients, combined treatment group of 30 patients , two groups were age, gender, body mass index, FBG, HbALc, blood pressure, UAER and other basic match. MAIN OUTCOME MEASURES .1 weeks for the detection of urinary albumin more than 3 times (ELISA) were 30 ~ 300 mg / 24 h, between all the medical records are othe
您可能关注的文档
- p53 and the occurrence of colorectal cancer metastasis treatment and prognosis and screening Relationship Status.doc
- P300 sub-components of the Research and Development.doc
- P33ING1 tumor suppressor gene in human skin tissue hemangioma and Statistical Analysis.doc
- p53 bcl2 and CD44v6 protein expression in breast cancer metastasis research.doc
- p53 gene in bladder cancer research.doc
- p53 and vascular endothelial growth endostatin gene transfection of HL60 cell growth on.doc
- p53 VEGF TSP1 in benign prostatic hyperplasia and prostate cancer patients with prostate carcinoma and its significance.doc
- p63 in Castleman disease and follicular lymphoma.doc
- P73α and p53 expression in breast cancer with chemotherapy drug sensitivity in the relationship between the.doc
- p73 gene and protein expression of the relationship between colorectal cancer.doc
文档评论(0)